This resulted an inversion of the differentiation arrest pattern seen in control cells in aged recipients compared to AML-ETO+ cells in aged recipients, demonstrating a strong and dominant influence of AML-ETO on cell differentiation programs. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.